Save the Date: Roche Virtual Event – Update following ASH 2022 Wednesday 14th December 2022

  We are pleased to invite investors and analysts to participate in our virtual event onWednesday, 14December 2022, highlighting Roche data presented at the American Society of Hematology 2022 Meeting and Exposition, from 10th to 13th December. 16:00 – 17:30 CET / 15:00 - 16:30 GMT10:00 – 11:30 am EST / 7:00 – 8:30 am PST An invitation with the detailed programme and registration link will follow soon.  Best regards, Bruno EschliHead of Investor Relations  Loren KalmHead of Investor Relations, North AmericaRoche Investor Relations Dr. BrunoEschliPhone: [phone]e-mail:[e-mail] Dr. SabineBorngr äberPhone: [phone]e-mail:[e-mail] Dr. BirgitMasjostPhone: [phone]e-mail:[e-mail] Dr. Gerard TobinPhone: [phone]e-mail:[e-mail]  Investor Relations North America Loren KalmPhone: [phone]e-mail:[e-mail] 

Source: Roche Investor Update - November 1, 2022 Category: Pharmaceuticals Source Type: news